£6.5M
The financing values the synthetic biology business at £30.5m post-money.
OG
Oxford Genetics
Oxford Genetics develops advanced technologies for drug and gene therapy.
Oxford, UK—Founded 2011
£6.5MTotal raised
Oxford Genetics provides advanced technologies and techniques for drug and gene therapy development. The company operates in the synthetic biology market, offering solutions for gene discovery, antibody therapy, and CRISPR gene editing.
Filed accounts
Cash at bank
Members only
Shareholders' funds
Members only
Turnover
Members only
Profit for the year
Members only
Employees
Members only
Cash, assets and headcount from Oxford Genetics's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
Ryan Cawood
Founder and CEO
Ryan brings founding and scientific leadership experience from Oxford Genetics, OXGENE, and WuXi Advanced Therapies.